Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Oxidative stress pathways/retinal cell protection" does not refer to a single molecule or receptor but rather encompasses a group of interconnected molecular pathways that regulate the cellular response to oxidative damage in retinal cells. The most prominent among these is the Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, which plays a central role in defending against oxidative stress by upregulating antioxidant and cytoprotective genes such as heme oxygenase 1 and NAD(P)H quinone oxidoreductase. Activation of this pathway—often through upstream signals like PI3K/Akt—protects retinal pigment epithelial cells and ganglion cells from injury caused by reactive oxygen species, contributing to the prevention or mitigation of diseases such as age-related macular degeneration and glaucoma. Small molecules including triptonide, triptolide, and certain flavonoids have been shown experimentally to activate this protective mechanism. However, since "oxidative stress pathways/retinal cell protection" is not itself a discrete molecular target but rather describes multiple overlapping biological processes involving several proteins and regulatory networks—including and not limited to Nrf2—the entry should be flagged as incorrect for use as a canonical therapeutic target name[1][3][5].
Activation of Nrf2 to induce antioxidant gene expression (e.g., HO1, NQO1); Inhibition of oxidative stress-induced cell death in retinal cells and ganglion cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid 2-related factor 2 signaling pathway (Nrf2 pathway).